A new topical drug formulation for ulcer patient

A New Topical Drug Formulation With Methanol Extract Of CASSIA AURICULATA WITH ALPHA TOCOPHEROL AND POVIDON IODINE VS REGULAR dressing solution for foot ulcer patients - Nil

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085198

Enrollment

Registered

2025-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S913- Open wound of foot

Interventions

Intervention1: New topical drug formulation of methanol extract of Cassia auriculata with povidone iodine and alpha tocopherol: A topical solution for foot ulcer for enhanced wound healing, to minimiz

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals

Exclusion criteria

Exclusion criteria: Pregnancy Coronary artery disease

Design outcomes

Primary

Measure	Time frame
The effectiveness of new topical solution in promoting wound healingTimepoint: Day 0,day 3,day 5,day 7	—

Secondary

Measure	Time frame
Evaluate efficacy of methanol extract of Cassia auriculata with povidone iodine & alpha tocopherolTimepoint: Day 0,3,5,7	—

Countries

India

Contacts

Public ContactSri Siva Shyla

Saveetha medical college and hospital

shyla_sri @hotmail.com8940002154

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026